
Vivek Subbiah/LinkedIn
Jul 13, 2025, 16:49
Vivek Subbiah: How to Foster Long-term Trust in the Biomedical Research Process?
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn:
“This article highlights technical and procedural considerations needed to support DCTs and identifies areas for trial innovation.
By making DCTs and technology platforms participant-centric and continuing to advance opportunities for innovation, researchers may accelerate scientific discovery, help participants feel their contributions are meaningful, and foster long-term trust in the biomedical research process.”
Title: Participants as Partners in Decentralized Clinical Trials
Journal: NEJM Evidence
Authors: Paul A. Harris, Alex C. Cheng
More posts featuring Vivek Subbiah on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 13, 2025, 16:49
Jul 13, 2025, 16:41
Jul 13, 2025, 16:40
Jul 13, 2025, 16:38
Jul 13, 2025, 16:05